Joan edukira
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aurreratua
  • Systemic review and economic e...
  • Erreferentzia bihurtu
  • SMS
  • Bidali
  • Imprimir
  • Erregistroa esportatu
    • Nora RefWorks
    • Nora EndNoteWeb
    • Nora EndNote
  • Permanent link
Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Xehetasun bibliografikoak
Egile Nagusiak: Clark, W, Raftery, J, Song, F, Barton, P, Cummins, C, Fry-Smith, A, Burls, A
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2003
  • Aleari buruzko argibideak
  • Deskribapena
  • Antzeko izenburuak
  • MARC erregistroa

Antzeko izenburuak

  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    nork: Clark, W, et al.
    Argitaratua: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    nork: Clark, W, et al.
    Argitaratua: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
    nork: W. Clark, et al.
    Argitaratua: (2003-01-01)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    nork: Chen, Y, et al.
    Argitaratua: (2006)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    nork: Chen, Y, et al.
    Argitaratua: (2006)

Bilaketa aukerak

  • Bilaketaren historia
  • Bilaketa aurreratua

Gehiago bilatu

  • Katalogoa arakatu
  • Bilaketa alfabetikoki
  • Esploratu kanalak
  • Erreserba egin ezazu
  • Berriak liburutegietan

Laguntza behar al duzu?

  • Bilaketa egiteko aholkuak
  • Galdetu liburuzainari
  • FAQ